How did FDA change sunscreen ingredient rules?

FDA expands allowed sunscreen ingredient list

The FDA expanded its list of allowed sunscreen ingredients to include bemotrizinol, a chemical compound already used in Europe and Asia. The change matters because it gives formulators another option for building sun-protection products in the U.S., while also signaling that regulators are continuing to evaluate additional UV filters used elsewhere.

From a public-health perspective, the development is primarily about availability and standards: sunscreen products depend on ingredient approvals to ensure they meet regulatory requirements for safety and effectiveness. By adding bemotrizinol, the FDA is effectively broadening the toolkit available to manufacturers—potentially affecting the types of lotions, creams, and other topical products that can be marketed.

For consumers, the practical takeaway remains consistent: sunscreen effectiveness depends on using the right product correctly (adequate quantity and reapplication), and ingredient updates don’t replace established guidance on sun protection behaviors.

If you’re choosing sunscreen, look for products labeled with broad-spectrum protection and appropriate SPF, and apply generously—especially when time in sun is expected. The FDA action mainly reduces regulatory friction for manufacturers; it does not automatically mean every new product will be better for every person.

Overall, the FDA’s decision highlights how U.S. sun-care regulations can evolve as additional ingredients gain review and approval, aligning the U.S. more closely with ingredient use patterns already established in other regions.